Getty, Endpoints News

In­side the race to make psy­che­delics 'main­stream med­i­ci­nes'

When Berra Yazar-Klosin­s­ki was wrap­ping up her PhD in mol­e­c­u­lar cell and de­vel­op­men­tal bi­ol­o­gy at UC San­ta Cruz, there was an unas­sum­ing lit­tle of­fice right down the road, hid­den in­side a bun­ga­low-style house with a postage-square lawn.

Tucked away on a busy street, the build­ing didn’t strike Yazar-Klosin­s­ki as the type of place where sci­en­tif­ic re­search would oc­cur. But in­side, she would learn, was the Mul­ti­dis­ci­pli­nary As­so­ci­a­tion for Psy­che­del­ic Stud­ies (MAPS), a non­prof­it work­ing on turn­ing psy­che­delics in­to med­i­cines for a host of men­tal ill­ness­es.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.